Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
PHARMACEUTICAL COMPOSITIONS COMPRISING ZD6474

No-Receipt date 2009-03544 - 15/10/2009
No-Filing date 20090402559 - 15/10/2009
No-Granting date 3070230 - 16/10/2009
No-EPO application date 05744858.1 - 18/05/2005
No-EPO granting date 1753431 - 19/08/2009
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2009 - 19/11/2009
Expiration date 19/05/2025
Kind of title Validation of European Patent
Legal status VALID
Priorities GB041137821/05/2004/GB
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/517
A61K 47/02
A61K 47/38

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
434205 GENZYME CORPORATION 500 KENDALL STREETCAMBRIDGE, MA 02142,USA UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
697877 STOTT, PAUL. WILLIAM, C/O ASTRAZENECA

Representatives
CodeFirstnameSurnameAddressTownZip
1602AIKATERINISIOTOUPATISION 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History
Date Description Comments Data before modification Data after modification
03/11/2016 Μεταβίβαση (7e802) ΑΡ.ΠΡΩΤ.5419/04-10-16,ΔΝΥ1142/26-10-16,ΚΩΔ.ΠΛΗΡ.1602 296549 AstraZeneca AB . ΣΟΥΗΔΙΑ 151 85 Sodertalje, SWEDEN 434205 Genzyme Corporation 500 Kendall Street ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02142,USA

Title Instruments

Payments history 20 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).